Wilkes-Barre, PA, is part of a region with world-class healthcare infrastructure, yet accessing specialized obesity treatment remains difficult for many. Weight Method eliminates the friction — a quick online assessment, a virtual consultation with a provider licensed in Pennsylvania, and your Tirzepatide prescription delivered to your door in Wilkes-Barre. No referrals, no waiting rooms, no commute.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Wilkes-Barre is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Wilkes-Barre, PA. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Wilkes-Barre, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Pennsylvania residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Wilkes-Barre address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
Suburban life around Wilkes-Barre comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide addresses the biology behind weight gain by reducing hunger signals and improving metabolic function, so Wilkes-Barre area residents can break patterns that willpower alone cannot fix. Weight Method prescribes Tirzepatide virtually, with medication delivered to your door.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Pennsylvania and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.